432 related articles for article (PubMed ID: 28569199)
1. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
[TBL] [Abstract][Full Text] [Related]
2. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis.
Fu Z; Deng B; Liao Y; Shan L; Yin F; Wang Z; Zeng H; Zuo D; Hua Y; Cai Z
BMC Cancer; 2013 Dec; 13():580. PubMed ID: 24314238
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway.
Li B; Yuan Z; Jiang J; Rao Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30420490
[TBL] [Abstract][Full Text] [Related]
4. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
5. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z
Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778
[TBL] [Abstract][Full Text] [Related]
6. Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy.
Li YL; Hu X; Li QY; Wang F; Zhang B; Ding K; Tan BQ; Lin NM; Zhang C
Mol Med Rep; 2018 Oct; 18(4):3882-3890. PubMed ID: 30106133
[TBL] [Abstract][Full Text] [Related]
7. Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z.
Zhang Z; Zhang Z; Li Q; Jiao H; Chong D; Sun X; Zhang P; Huo Q; Liu H
J Bioenerg Biomembr; 2017 Jun; 49(3):265-272. PubMed ID: 28547157
[TBL] [Abstract][Full Text] [Related]
8. Shikonin kills glioma cells through necroptosis mediated by RIP-1.
Huang C; Luo Y; Zhao J; Yang F; Zhao H; Fan W; Ge P
PLoS One; 2013; 8(6):e66326. PubMed ID: 23840441
[TBL] [Abstract][Full Text] [Related]
9. Shikonin Causes Non-apoptotic Cell Death in B16F10 Melanoma.
Ahmad H; Crotts MS; Jacobs JC; Baer RW; Cox JL
Anticancer Agents Med Chem; 2023; 23(16):1880-1887. PubMed ID: 37393553
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
Shahsavari Z; Karami-Tehrani F; Salami S
Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
[TBL] [Abstract][Full Text] [Related]
12. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
[TBL] [Abstract][Full Text] [Related]
13. Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer.
Zang F; Rao Y; Zhu X; Wu Z; Jiang H
Mol Med; 2020 Apr; 26(1):28. PubMed ID: 32268876
[TBL] [Abstract][Full Text] [Related]
14. Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis.
Wu Z; Wu LJ; Li LH; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2004 Sep; 6(3):155-66. PubMed ID: 15224412
[TBL] [Abstract][Full Text] [Related]
15. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
[TBL] [Abstract][Full Text] [Related]
16. Negatively-regulated necroptosis by autophagy required caspase-6 activation in TNFα-treated murine fibrosarcoma L929 cells.
Ye YC; Wang HJ; Chen L; Liu WW; Tashiro S; Onodera S; Xia MY; Ikejima T
Int Immunopharmacol; 2013 Nov; 17(3):548-55. PubMed ID: 23941769
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Lung Cancer by 2-Methoxy-6-Acetyl-7-Methyljuglone Through Induction of Necroptosis by Targeting Receptor-Interacting Protein 1.
Sun W; Yu J; Gao H; Wu X; Wang S; Hou Y; Lu JJ; Chen X
Antioxid Redox Signal; 2019 Jul; 31(2):93-108. PubMed ID: 30556404
[No Abstract] [Full Text] [Related]
18. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
19. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways.
Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
[TBL] [Abstract][Full Text] [Related]
20. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
Wada N; Kawano Y; Fujiwara S; Kikukawa Y; Okuno Y; Tasaki M; Ueda M; Ando Y; Yoshinaga K; Ri M; Iida S; Nakashima T; Shiotsu Y; Mitsuya H; Hata H
Int J Oncol; 2015 Mar; 46(3):963-72. PubMed ID: 25530098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
